Cell Therapy for Corneal Endothelial Cell Dysfunction
NCT06726174
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Corneal Endothelial Cell Dysfunction
Interventions
DRUG:
ECCEC
Sponsor
National Taiwan University Hospital